MetLife Investment Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $397K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $389K | Sell |
|
|||||
|
2024
Q4 | $496K | Buy |
|
|||||
|
2024
Q3 | $229K | Hold |
|
|||||
|
2024
Q2 | $170K | Buy |
|
|||||
|
2024
Q1 | $144K | Sell |
|
|||||
|
2023
Q4 | $337K | Hold |
|
|||||
|
2023
Q3 | $237K | Hold |
|
|||||
|
2023
Q2 | $295K | Hold |
|
|||||
|
2023
Q1 | $311K | Hold |
|
|||||
|
2022
Q4 | $336K | Hold |
|
|||||
|
2022
Q3 | $374K | Buy |
|
|||||
|
2022
Q2 | $337K | Sell |
|
|||||
|
2022
Q1 | $454K | Buy |
|
|||||
|
2021
Q4 | $404K | Hold |
|
|||||
|
2021
Q3 | $418K | Hold |
|
|||||
|
2021
Q2 | $532K | Hold |
|
|||||
|
2021
Q1 | $348K | Buy |
|
|||||
|
2020
Q4 | $43.7K | Buy |
|
|||||
|
2020
Q3 | $21.5K | Sell |
|
|||||
|
2020
Q2 | $127K | Buy |
|